Inovio Pharmaceuticals
Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020).
Q7108
biotechnology
Concept
Q1405450
synthetic DNA
Concept
Q12078
cancer
Concept
Q166231
infectious disease
Concept
Q134808
vaccine
Concept
Q84263196
COVID-19
Concept
Q30283331
Inovio Pharmaceuticals
ORG
2020-04-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
April 2020
DATE
2020-06-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
June 2020
DATE
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
industry